BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31160308)

  • 21. INI1 induces interferon signaling and spindle checkpoint in rhabdoid tumors.
    Morozov A; Lee SJ; Zhang ZK; Cimica V; Zagzag D; Kalpana GV
    Clin Cancer Res; 2007 Aug; 13(16):4721-30. PubMed ID: 17699849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium.
    Donner LR; Wainwright LM; Zhang F; Biegel JA
    Hum Pathol; 2007 Jun; 38(6):935-9. PubMed ID: 17376508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.
    Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY
    Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5(+/-);p53(+/-) mice.
    DelBove J; Kuwahara Y; Mora-Blanco EL; Godfrey V; Funkhouser WK; Fletcher CD; Van Dyke T; Roberts CW; Weissman BE
    Mol Carcinog; 2009 Dec; 48(12):1139-48. PubMed ID: 19676100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development.
    Kuwahara Y; Mora-Blanco EL; Banine F; Rogers AB; Fletcher C; Sherman LS; Roberts CW; Weissman BE
    Int J Cancer; 2013 Jun; 132(12):2767-77. PubMed ID: 23197309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression.
    Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
    Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
    Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors.
    DeCristofaro MF; Betz BL; Wang W; Weissman BE
    Oncogene; 1999 Dec; 18(52):7559-65. PubMed ID: 10602515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of a mouse model of atypical teratoid/rhabdoid tumor of the central nervous system through combined deletion of Snf5 and p53.
    Ng JM; Martinez D; Marsh ED; Zhang Z; Rappaport E; Santi M; Curran T
    Cancer Res; 2015 Nov; 75(21):4629-39. PubMed ID: 26363008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
    Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
    Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric extra-renal rhabdoid tumors with unusual morphology: a diagnostic pitfall for small biopsies.
    Alaggio R; Boldrini R; Di Venosa B; Rosolen A; Bisogno G; Magro G
    Pathol Res Pract; 2009; 205(7):451-7. PubMed ID: 19243895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation.
    Wang X; Lee RS; Alver BH; Haswell JR; Wang S; Mieczkowski J; Drier Y; Gillespie SM; Archer TC; Wu JN; Tzvetkov EP; Troisi EC; Pomeroy SL; Biegel JA; Tolstorukov MY; Bernstein BE; Park PJ; Roberts CW
    Nat Genet; 2017 Feb; 49(2):289-295. PubMed ID: 27941797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways.
    Chun HE; Lim EL; Heravi-Moussavi A; Saberi S; Mungall KL; Bilenky M; Carles A; Tse K; Shlafman I; Zhu K; Qian JQ; Palmquist DL; He A; Long W; Goya R; Ng M; LeBlanc VG; Pleasance E; Thiessen N; Wong T; Chuah E; Zhao YJ; Schein JE; Gerhard DS; Taylor MD; Mungall AJ; Moore RA; Ma Y; Jones SJM; Perlman EJ; Hirst M; Marra MA
    Cancer Cell; 2016 Mar; 29(3):394-406. PubMed ID: 26977886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations.
    Forest F; David A; Arrufat S; Pierron G; Ranchere-Vince D; Stephan JL; Clemenson A; Delattre O; Bourdeaut F
    Am J Surg Pathol; 2012 Dec; 36(12):1892-6. PubMed ID: 23154773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013.
    Bourdeaut F; Chi SN; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):346-51. PubMed ID: 25468731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
    Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B
    Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB).
    Bartelheim K; Sumerauer D; Behrends U; Kodetova D; Kucera F; Leuschner I; Neumayer P; Oyen F; Rübe C; Siebert R; Schneppenheim R; Seeringer A; Vasovcak P; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):379-83. PubMed ID: 24972932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.
    Carugo A; Minelli R; Sapio L; Soeung M; Carbone F; Robinson FS; Tepper J; Chen Z; Lovisa S; Svelto M; Amin S; Srinivasan S; Del Poggetto E; Loponte S; Puca F; Dey P; Malouf GG; Su X; Li L; Lopez-Terrada D; Rakheja D; Lazar AJ; Netto GJ; Rao P; Sgambato A; Maitra A; Tripathi DN; Walker CL; Karam JA; Heffernan TP; Viale A; Roberts CWM; Msaouel P; Tannir NM; Draetta GF; Genovese G
    Cancer Cell; 2019 Feb; 35(2):204-220.e9. PubMed ID: 30753823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital Disseminated Extrarenal Malignant Rhabdoid Tumor.
    Boudjemaa S; Petit A; Dainese L; Bourdeaut F; Lipsett J; Coulomb A
    Pediatr Dev Pathol; 2015; 18(5):401-4. PubMed ID: 25751458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.